SCHEMBL26817844

SCHEMBL26817844

CC(C)C(=O)N1CCN(C(=O)OC(C)(C)C)C(C)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SETD7 Q8WTS6 2/20 0.47
MAP4K4 O95819 1/20 0.39
SPR P35270 2/20 0.38
HTT P42858 2/20 0.38
ATM Q13315 1/20 0.38
GPR119 Q8TDV5 2/20 0.38
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK3 Q15120 1/20 0.37
PDK4 Q16654 1/20 0.37
USP2 O75604 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HSD17B10 Q99714 1/20 0.36
NTRK1 P04629 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17560451 0.88 SETD7 (0.47) SETD7SPRHTTATMGPR119
SCHEMBL26204619 0.88 SETD7 (0.47) SETD7SPRHTTATMGPR119
SCHEMBL17560452 0.88 SETD7 (0.47) SETD7SPRHTTATMGPR119
SCHEMBL4336794 0.86 SETD7 (0.52) SETD7MAP4K4SPRUSP2SMN1; SMN2
SCHEMBL3639918 0.83 SETD7 (0.50) SETD7MAP4K4SPRGPR119PDK1
SCHEMBL2053722 0.83 SETD7 (0.50) SETD7MAP4K4SPRGPR119PDK1
SCHEMBL15105056 0.83 SETD7 (0.50) SETD7MAP4K4SPRGPR119PDK1
SCHEMBL31094813 0.83 SETD7 (0.50) SETD7MAP4K4SPRGPR119PDK1
SCHEMBL18702111 0.82 SETD7 (0.49) SETD7MAP4K4SPRGPR119PDK1
SCHEMBL4684385 0.82 SETD7 (0.49) SETD7MAP4K4SPRGPR119PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023239768-A1 TRICYCLIC TRIAZOLO COMPOUNDS AS DGK INHIBITORS INCYTE CORPORATION (US) 2023-12-14 WO disclosed
US-11827640-B2 Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators ILDONG PHARMACEUTICAL CO., LTD. (KR) 2023-11-28 US disclosed
US-11827640-B2 Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators ILDONG PHARMACEUTICAL CO., LTD. (KR) 2023-11-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827640-B2 Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators PDE4A, PDE4B, PDE5A SETD7 4153/4885MAP4K4 1410/4885SPR 3460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.